Thermo Fisher Scientific Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay

Tuesday, 15 December, 2020 | Supplied by: Thermo Fisher Scientific

Thermo Fisher Scientific has announced a direct-from-saliva PCR test for COVID-19 to enable widespread, high-frequency surveillance testing. The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and is designed to simplify lab workflows using instruments that are widely available to deliver data quickly.

By performing the test directly from raw saliva and eliminating the need for equipment, materials, time and labour associated with nucleic acid extraction, the assay helps labs meet the CDC turnaround time recommendations. It provides global communities with access to surveillance testing that is easy to implement, so they can manage the spread of COVID-19 and return to a sense of normalcy.

The assay is suitable for institutions of higher learning with existing laboratories. Universities that do not have labs on campus can also benefit by partnering with third-party testing providers. These reference labs can leverage the assay’s workflow to support increases in testing volume.

Phone: 1300 735 292
Related Products

Cloud-Clone ELISA Kit for Human Chemokine C-C-Motif Receptor 4 (CCR4)

The assay is highly sensitive, with a minimum detection dose of 0.056 ng/mL, and is suitable for...

Cayman Chemical Cellular Fatty Acid (C16) Uptake Assay Kit

Cayman Chemical's Cellular Fatty Acid (C16) Uptake Assay Kit is a convenient tool for...

PerkinElmer HIVE scRNAseq Solution

The HIVE scRNAseq Solution integrates sample storage and single-cell profiling into a complete...

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd